[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"rotator-cuff-tears-of-the-shoulder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:rotator-cuff-tears-of-the-shoulder":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,44,66,96,125,147,174],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100573073","integrity-implant-system-post-market-clinical-follow-up-study-100573073",false,"NCT06741527","Integrity Implant System Post Market Clinical Follow-Up Study","Post Market Confirmatory Interventional Clinical Study of the Integrity Implant System Used for Rotator Cuff Tear Augmentation","1. At least 18 years of age\n2. Able (with assistance from LAR, if necessary) to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures.\n3. Able to complete all Patient Reported Outcome Measure (PROM) questionnaires.\n4. Fully understands study requirements and able to return for all required follow-up visits and assessments.\n5. Able to comply with all post-operative physician prescribed rehabilitation instructions.\n6. Index shoulder rotator cuff tendon tear surgical access may be performed using mini-open, single-portal arthroscopic or multi-portal arthroscopic intervention\n7. Meets all intended use and indications for use defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:\n\nIndex shoulder rotator cuff tendon tear needs management and protection from injury\n\nIndex shoulder has no substantial loss of tendon tissue\n\nIndex shoulder rotator cuff tendon tear footprint allows approximation of soft tissue and fixation of the Integrity Implant to tendon tissue using an Integrity Tissue Tack\n\nIndex shoulder rotator cuff tendon tear footprint allows fixation of the Integrity Implant to bone using the Integrity Bone Staple\n\nExclusion Criteria\n\nThe subject exclusion criteria are as follows:\n\n1. Medical condition that in the PI's opinion would place the subject at risk or interfere with the study\n2. Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study)\n3. Pregnant, breastfeeding, or plans to become pregnant during the study\n4. History of poor compliance with medical treatment of any kind\n5. Deemed contraindicated for MRI by the PI\n6. Previous rotator cuff surgery (any type) on the index shoulder\n7. Current instability of the index shoulder\n8. Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length \\>5cm)\n9. Chondromalacia of index shoulder ≥ Grade 3\n10. Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3\n11. Insulin dependent Type I Diabetes\n12. History of heavy smoking (≥ 1 pack per day) within last 6-months\n13. History of auto-immune or immunodeficiency disorders\n14. Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases)\n15. Oral steroid use in the last 2-months or injectable steroid use in the last 3-months\n16. History of cognitive or mental health status that interferes with study participation\n17. Poor comprehension of English language\n18. Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:\n\n18.1 Rotator cuff tendon tear is deemed irreparable by the PI\n\n18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon\n\n18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue\n\n18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement\n\n18.5 Presence of infection\n\n18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period\n\n18.7 Hypersensitivity to any of the Integrity Implant System components\n\n18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation\n\n18.9 Inadequate quality of bone for Integrity Bone Staple fixation","ALL","18 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"NA","The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).",[26],"Rotator Cuff Tears of the Shoulder",[28,29,30],"Rotator Cuff Repair","Shoulder repair","Integrity Implant","RECRUITING","2026-06-22",{"date":34,"type":35},"2026-06-24","ACTUAL",{"date":37,"type":35},"2025-02-01",{"date":39,"type":20},"2027-10",{"name":41,"class":42},"Anika Therapeutics, Inc.","INDUSTRY",9,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":65},"100578988","sinefix-2022-comparative-phase-100578988","NCT06818448","SINEFIX-2022 Comparative Phase","Pre-market Clinical Investigation Inovedis SINEFIX","Inclusion Criteria:\n\n* Patient indicated for surgical repair of the rotator cuff tear according to current guidelines\n* Patient aged 18 years or older\n* Up to 2 cm tear size (medio-lateral) of supraspinatus, infraspinatus\n* Up to 2 cm tear size (anterior-posterior) of supraspinatus, infraspinatus\n\nExclusion Criteria:\n\n* Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder\n* History of alcoholism, drug abuse, psychological or other emotional problems likely to interfere with participation in the study follow-up schedule and assessments\n* Inflammatory arthropathies\n* Subject with a contraindication\u002Fnon-compliance for MRI examination\n* Subject 's unwillingness to undergo surgical rotator cuff repair, participate in post-operative rehabilitation program, and \u002F or adhere to follow up schedule\n* Pregnant and breastfeeding woman",{"count":52,"type":20},60,[23],"Shoulder pain is one of the most commonly reported musculoskeletal complaints, which negatively affects upper limb use, night rest, daily life activities, work, sports performance and autonomy. Rotator cuff disease represents the most common cause of shoulder pain and it is responsible for up to 70% of all shoulder related visits to clinicians. Its incidence furthermore is expected to grow as the population ages. A wide range of conditions are included under the umbrella term of rotator cuff disease, including rotator cuff tendinopathy, subacromial bursal pathology, and partial-thickness or full- thickness rotator cuff tears (RCTs). The latter ones, i.e. rotator cuff tears, form the indications for which the test devices, the SINEFIX implant and instruments, are intended.\n\nDespite the high prevalence of this condition, the pathophysiology and healing potential are not well understood, making the condition challenging to predictably treat in some patient populations. RCTs may occur in young people as a consequence of trauma (e.g. acute shoulder dislocation), however RCTs typically present in middle-aged or elderly people and cannot always be attributed to precipitating events or trauma. Instead, they can be attributed to degenerative processes, and are therefore referred to as degenerative RCTs.\n\nFor RCTs, treatment options include both surgical and non-surgical (conservative) procedures.\n\nIn this context, the SINEFIX implant and instruments were developed to treat adult patients with rotator cuff lesions of size up to 2 cm through arthroscopic reconstruction.\n\nA pilot study phase investigating the SINEFIX implant and instruments was conducted and showed adequate performance, usability and preliminary safety. Hence, the device is now being tested on a larger number of participants as part of the comparative study phase.",[26],"2026-06-02",{"date":58,"type":35},"2026-06-03",{"date":60,"type":35},"2025-09-16",{"date":62,"type":20},"2028-03",{"name":64,"class":42},"BAAT Medical Products B.V.",2,{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":16,"minAge":72,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":76,"conditions":77,"keywords":81,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":95},"100508867","post-market-clinical-follow-up-pmcf-study-of-the-pitch-patch-for-the-augmentation-or-reinforcement-of-the-rotator-cuff-100508867","NCT05906004","Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff","Inclusion Criteria:\n\n* Patient has been treated using a Pitch-Patch device for augmentation or reinforcement of the rotator cuff 2-2.5years prior to enrolment.\n* Patient has a baseline Constant Murley Score (CMS), assessed within 30 days prior to implantation of the device.\n* Patient must be 16 years old or above.\n* Patient is willing to participate in the study, and having been informed of the nature of the study, has provided written informed consent as approved by the Ethics Committee (EC).\n\nExclusion Criteria:\n\n\\- The Pitch-Patch has been used outside its intended use.","16 Years",{"count":74,"type":20},37,"OBSERVATIONAL","This is a clinical investigation study. It will verify the long-term safety and performance of the Pitch-Patch when implanted to reinforce partially repairable rotator cuff tears and used as described by the manufacturer's instructions.\n\nThe medical device in this study is already on the market and is manufactured by Xiros Ltd.\n\nThe Pitch-Patch is a single-use polyester prosthesis available in two sizes (30x20mm and 35x25mm). It is reinforced around the perimeter and around each eyelet to provide strength and stability to the device and repair.\n\nThe study will collect data on patients who meet the entry criteria and have received the device.\n\nThis is a single-armed study, meaning all patients will have a Pitch-Patch. The total length of the study is expected to be 3 years.\n\nA minimum of 37 patients will be enrolled into the study. Patients will be enrolled at a study specific follow up visit 2-2.5 years after implant, and data for baseline, procedure, and other time points prior to 2 years (3month, 6month, and 1 year post surgery) will be collected retrospectively from medical records if available.",[78,79,26,80],"Rotator Cuff Tear","Rotator Cuff Tears","Rotator Cuff Injuries",[82,28,83,84,85],"Rotator Cuff Reinforcement","Pitch-Patch","Xiros","Rotator Cuff Augmentation","2026-05-12",{"date":88,"type":35},"2026-05-15",{"date":90,"type":20},"2026-05",{"date":92,"type":20},"2029-12",{"name":94,"class":42},"Xiros Ltd",1,{"id":97,"slug":98,"hasResults":11,"nctId":99,"briefTitle":100,"officialTitle":100,"acronym":4,"eligibilityCriteria":101,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":102,"enrollmentInfo":103,"targetDuration":4,"studyType":21,"phases":105,"briefSummary":106,"conditions":107,"keywords":112,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":119,"completionDateStruct":120,"leadSponsor":122,"locationsCount":95},"100634930","the-effect-of-an-exercise-program-based-on-attentional-focus-shifting-on-clinical-outcomes-in-rotator-cuff-related-shoulder-pain-100634930","NCT07546084","The Effect of an Exercise Program Based on Attentional Focus Shifting on Clinical Outcomes in Rotator Cuff Related Shoulder Pain","Inclusion Criteria:\n\n* Having symptoms persisting for at least 3 months\n* Experiencing pain intensity of at least 3 on the Numeric Pain Rating Scale (NPRS) during activity\n* Presence of a painful arc during shoulder flexion or abduction\n* Positive Neer test or Hawkins-Kennedy test\n* Pain provoked by resisted external rotation\u002Fabduction of the humerus, or a positive Jobe (Empty Can) test\n* Having a clinical diagnosis of subacromial pain syndrome, rotator cuff tendinopathy, subacromial bursitis, or symptomatic partial\u002Ffull-thickness rotator cuff tear\n* Being able to understand and complete questionnaires in Turkish\n\nExclusion Criteria:\n\n* Presence of adhesive capsulitis (≥30% limitation in passive range of motion)\n* Advanced osteoarthritis of the shoulder\n* History of fracture or dislocation affecting the shoulder region\n* Advanced acromioclavicular joint pathology\n* Massive rotator cuff tear (positive lag signs)\n* Previous shoulder surgery\n* Presence of neurological disorders\n* Diagnosis of rheumatoid arthritis\n* History of cancer\n* Symptomatic cervical spine pathology\n* Corticosteroid injection to the shoulder within the past 6 weeks\n* Cognitive impairments that may interfere with the ability to perform clinical tasks or execute attention shift-based exercises","65 Years",{"count":104,"type":20},46,[23],"The aim of this clinical trial is to investigate the effects of an attention shift-based rehabilitation program on clinical outcomes in individuals with rotator cuff-related shoulder pain (RCRSP). The study will evaluate the effects of an attention shift approach, in which motor tasks targeting regions outside the shoulder are performed concurrently with standard shoulder exercises, on pain, functional status, and pain catastrophizing. These results will be compared with those of a standard shoulder rehabilitation program.\n\nThe main questions this study aims to answer are:\n\nIs there a difference in pain levels between individuals with RCRSP who participate in an attention shift-based rehabilitation program and those who participate in a standard exercise program? Is there a difference between these two rehabilitation approaches in terms of shoulder function and pain catastrophizing?\n\nParticipants will:\n\nBe randomly assigned to either an attention shift-based rehabilitation group or a standard shoulder rehabilitation group Participate in supervised exercise sessions twice per week for 6 weeks Attend sessions lasting approximately 60-75 minutes Undergo clinical assessments at baseline and at week 6",[108,109,110,111,26],"Rotator Cuff Related Shoulder Pain","Subacromial Pain Syndrome","Shoulder Bursitis","Shoulder Tendinopathy",[113,114,115],"Rotator cuff","Shoulder pain","attention shift","2026-04-20",{"date":118,"type":35},"2026-04-22",{"date":88,"type":20},{"date":121,"type":20},"2027-06-15",{"name":123,"class":124},"Istanbul University","OTHER",{"id":126,"slug":127,"hasResults":11,"nctId":128,"briefTitle":129,"officialTitle":130,"acronym":4,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":132,"targetDuration":4,"studyType":21,"phases":134,"briefSummary":135,"conditions":136,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":95},"100627434","lok-suture-anchors-safety--performance-trial-100627434","NCT07448584","Lok™ Suture Anchors Safety & Performance Trial","Evaluation of the Safety and Performance of the Lok™ Suture Anchors Range and Associated Instrumentation - Multicenter Interventional and Single Blind Randomized Clinical Trial","Inclusion Criteria:\n\n* Consent to participate in the study: oral and written.\n* Man or woman over 18 years old with bone maturity finished.\n* Presented with one of the following indications:\n\n  * Rotator cuff lesion (tear or calcific tendinopathy) associated to a pathology of the long head of the biceps,\n  * Gleno-humeral instability,\n  * partial articular-sided tendon avulsion \\[PASTA\\] lesion.\n* MRI or arthrogram proving the rotator cuff lesion and long head of the biceps tendon injury, or the labrum injury, or PASTA injury.\n\nNon inclusion Criteria:\n\n* Radiographic sign of fracture: glenoid or lesser tuberosity.\n* Major trauma to the shoulder joint.\n* Any active infection or avascular necrosis.\n* Inflammatory joint disease.\n* Moderate to severe degenerative glenohumeral arthropathy (Kellgren-Lawrence Grade 3 or 4).\n* Bone pathologies compromising anchorage (cystic changes, severe osteopenia).\n* Pathological conditions of soft tissues impairing suture fixation.\n* Known hypersensitivity to implant material (PEEK and carbon or Polyethylene).\n* Anterior ipsilateral surgeries performed on the joint space.\n* Physical conditions that would eliminate, or tend to eliminate, adequate anchoring support or delay healing.\n* Contraindications from the instructions for use of the medical devices used.\n* Conditions that would limit the subject's ability or willingness to restrict activities or follow instructions during the healing period.\n* Inability to complete questionnaires: language problems, who do not speak\u002Fread\u002Funderstand French.\n* Pregnant or breastfeeding women.\n* Persons deprived of liberty or under guardianship.\n* Patients unable to undergo medical monitoring of the trial.\n* Psychiatric illnesses, cognitive disorders, or health problems that prevent informed consent.\n* Participation in another clinical trial.\n* Life expectancy of less than 12 months.\n* No health insurance.",{"count":133,"type":20},216,[23],"The aim of this study is to evaluate the performance and safety of Move-Up's lok™ system (lok™ suture anchors range and associated instrumentation). These devices will be evaluated at approximately 3, 6 and 12 months with 3 scoring criteria: Constant score, VAS pain score, and subjective shoulder value score (SSV). At the 6-month and 12-month post-operative visit, tendon healing, and the absence of recurrence of rupture or failure to heal in patients treated with lok™ anchors will also be analyzed.\n\nThe Sugaya score on ultrasound imaging will be used for this assessment. Adverse Events (AEs) and Serious Adverse Events (SAEs) will be assessed after the surgery and at each follow-up (1, 3, 6 and 12 months after the surgery).",[26,137],"Labrum Injury","2026-04-14",{"date":140,"type":35},"2026-04-15",{"date":142,"type":35},"2026-03-05",{"date":144,"type":20},"2027-08",{"name":146,"class":42},"Move Up SAS",{"id":148,"slug":149,"hasResults":11,"nctId":150,"briefTitle":151,"officialTitle":151,"acronym":4,"eligibilityCriteria":152,"healthyVolunteers":11,"sex":16,"minAge":153,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":21,"phases":156,"briefSummary":157,"conditions":158,"keywords":159,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":173},"100586643","fiberlocker-system-augmentation-of-rotator-cuff-repairs-100586643","NCT06918041","FiberLocker® System Augmentation of Rotator Cuff Repairs","Inclusion Criteria:\n\n1. The Subject is between the ages of 30 and 70 years.\n2. Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)\n3. Tear size ≥ 2 cm\n4. Primary rotator cuff repair\n5. Subject preoperative MRI obtained within 1 year prior to surgery\n\nExclusion Criteria:\n\n1. The Subject is unable or unwilling to sign the Patient Informed Consent, approved by the Institutional Review Board.\n2. The Subject objects to the use of the FiberLocker® System\n3. History or known allergy or intolerance to polyester\n4. Complete full-thickness subscapularis tears of \\> than the superior 1\u002F3 of the tendon (Lafosse grade 3 and above)\n5. Hamada grade III and above\n6. Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph\n7. Recurrent shoulder instability\n8. Corticosteroid injection in the operative shoulder within three months before surgery\n9. Subjects with inflammatory or auto-immune based joint diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)\n10. Subjects with current acute infection in the area surrounding the surgical site\n11. Revision rotator cuff repair\n12. Pregnant or planning to become pregnant during the study period\n13. Subject is breastfeeding during the study period\n14. Subject has conditions or circumstances that would interfere with study requirements\n\nIntraoperative Exclusion Criteria:\n\n1. Partial rotator cuff repairs\n2. Lafosse grade 3 or higher subscapularis tears\n3. Limited space for implant delivery\n4. FiberLocker® System cannot be used as indicated","30 Years","70 Years",{"count":52,"type":20},[23],"The purpose of this study is to prospectively evaluate healing, functional clinical outcomes, and safety of arthroscopic rotator cuff repairs augmented with the FiberLocker® System (encompassing the SpeedPatch® PET and the FiberLocker® Instrument SN).\n\nThe primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively.\n\nThe secondary outcome measures are the Sugaya classification, Goutallier Stage and tendon quality based on MRI as well as objective scores and patient-reported outcome measures (PROMs) from validated outcome scoring systems.",[78,79,26],[79,28,160,161,162,163],"Augmentation","Reinforcement","Mechanical Augmentation","Rotator Cuff Degeneration","2025-11-27",{"date":166,"type":35},"2025-12-01",{"date":168,"type":35},"2025-08-05",{"date":170,"type":20},"2028-04-01",{"name":172,"class":42},"ZuriMED Technologies Inc.",4,{"id":175,"slug":176,"hasResults":11,"nctId":177,"briefTitle":178,"officialTitle":179,"acronym":4,"eligibilityCriteria":180,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":181,"targetDuration":4,"studyType":21,"phases":182,"briefSummary":183,"conditions":184,"keywords":185,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":190,"lastUpdatePostDateStruct":191,"startDateStruct":193,"completionDateStruct":195,"leadSponsor":197,"locationsCount":95},"100611343","acne-face-wash-for-reducing-the-contamination-rate-in-arthroscopic-rotator-cuff-repair-surgery-100611343","NCT07239349","Acne Face Wash for Reducing the Contamination Rate in Arthroscopic Rotator Cuff Repair Surgery","Investigating Whether Preoperative Use of Acne Face Wash for Cleansing the Face, Neck, and Chest Helps Reduce the Contamination Rate of Cutibacterium Acnes in Arthroscopic Rotator Cuff Repair Surgery","Inclusion Criteria:\n\n* rotator cuff tear\n* scheduled for arthroscopic rotator cuff repair surgery\n\nExclusion Criteria:\n\n* history of shoulder fracture\n* previous shoulder surgeries\n* tatoo on the shoulder",{"count":19,"type":20},[23],"Previous studies have shown that even when following standard sterilization protocols, the positive culture rate of Cutibacterium acnes can still be as high as 30%. In recent years, several studies have reported that preoperative skin preparation of the shoulder, such as applying benzoyl peroxide (BPO) to the skin, can effectively reduce the cutaneous bacterial load of C. acnes and even decrease its incidence in the shoulder joint or surgical sutures after surgery. However, most of the existing studies have focused on arthroplasty, and robust evidence regarding contamination in rotator cuff surgery remains lacking. Therefore, this study aims to investigate whether preoperative skin preparation with a 10% BPO acne cleanser can effectively reduce contamination in rotator cuff surgery. The findings will help guide future clinical practice in preoperative preparation. This study will adopt a prospective randomized design. Patients will be randomly assigned (using a random number table) into two groups: the control group and the BPO cleanser group. All patients will receive instructions on preoperative skin cleansing. Patients in the control group will follow the current routine practice in our institution, cleansing the surgical site (shoulder) with soap or body wash. Patients in the BPO group, in addition to routine preoperative instructions, will receive specific guidance on cleansing the shoulder and surrounding skin. They will be provided with a 10% BPO acne cleanser and instructed to use it on the shoulder and surrounding area during bathing the day before surgery. After surgical disinfection, skin samples will be collected for bacterial culture. In addition, a segment of surgical suture will be obtained postoperatively for bacterial culture.",[26],[186,187,188,189],"rotator cuff tear","arthroscopy","benzoyl peroxide","Cutibacterium acnes","2025-11-16",{"date":192,"type":35},"2025-11-20",{"date":194,"type":20},"2025-11-18",{"date":196,"type":20},"2027-11-18",{"name":198,"class":124},"National Taiwan University Hospital"]